The Oncology Institute (TOI)
(Delayed Data from NSDQ)
$4.28 USD
+0.12 (2.88%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $4.29 +0.01 (0.23%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, The Oncology Institute, Inc. has a market cap of $371.21M, which represents its share price of $4.16 multiplied by its outstanding shares number of 89.23M. As a small-cap company, TOI's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TOI 4.28 +0.12(2.88%)
Will TOI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TOI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TOI
The Oncology Institute, Inc. (TOI) Reports Q2 Loss, Misses Revenue Estimates
TOI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TOI
Three new option listings and one option delisting on July 24th
Oncology Institute (TOI) Receives Outperform Rating from Noble Capital | TOI Stock News
Oncology Institute initiated with bullish view at Noble Capital, here's why
Video: Friday Sector Laggards: Hospital & Medical Practitioners, Paper & Forest Products
Oncology Institute (TOI) Receives Positive Coverage with Buy Rating | TOI Stock News